Paperpal Prime Logo

Acta Pharmaceutica : Impact Factor & More

eISSN: 1846-9558pISSN: 1330-0075
JournalOpen Access

Key Metrics

CiteScore
4.5
Impact Factor
< 5
SJR
Q3Pharmacology
SNIP
0.9
Recommended pre-submission checks
Powered by Paperpal by Editage

Acta Pharmaceutica Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SCIENDO
Language English
Frequency Quarterly
Article Processing ChargesEUR 900
Publication Time20
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorCroatian Pharmaceutical Society
FrequencyQuarterly
Publication Start Year1951
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 20
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Acta Pharmaceutica ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Acta Pharmaceutica

Size exclusion chromatography as a characterization tool for quality control of marine biopharmaceutical keyhole limpet hemocyanin.
  • 23 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Nanocarrier based drug delivery for rheumatoid arthritis: Current strategies and future directions.
  • 23 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Syringin inhibits insulin resistance through the PI3K/AKT pathway.
  • 13 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
First-in-class HPLC-fluorescence method for quantification of roscovitine in plasma: Greenness assessment and application to pharmacokinetic studies in rats.
  • 13 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Adverse event reporting of golimumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database.
  • 13 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
A meta-analysis of the effects of Zingiber officinale on metabolic indices among patients with type 2 diabetes.
  • 23 Sep 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Size exclusion chromatography as a characterization tool for quality control of marine biopharmaceutical keyhole limpet hemocyanin.
  • 23 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Nanocarrier based drug delivery for rheumatoid arthritis: Current strategies and future directions.
  • 23 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Syringin inhibits insulin resistance through the PI3K/AKT pathway.
  • 13 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
First-in-class HPLC-fluorescence method for quantification of roscovitine in plasma: Greenness assessment and application to pharmacokinetic studies in rats.
  • 13 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
Adverse event reporting of golimumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database.
  • 13 Oct 2026
  • Acta pharmaceutica (Zagreb, Croatia)
A meta-analysis of the effects of Zingiber officinale on metabolic indices among patients with type 2 diabetes.
  • 23 Sep 2026
  • Acta pharmaceutica (Zagreb, Croatia)

FAQs on Acta Pharmaceutica